Publication | Open Access
Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease
25
Citations
24
References
2023
Year
In this cohort of 4618 older patients with CKD, the 90-day risk of serious adverse events was higher among those who started low-dose methotrexate than those who started hydroxychloroquine. If verified, these risks should be balanced against the benefits of low-dose methotrexate use.
| Year | Citations | |
|---|---|---|
Page 1
Page 1